Eaton Vance Worldwide Health Sci A
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
Vitals
YTD Return
-17.6%
1 yr return
3.9%
3 Yr Avg Return
14.3%
5 Yr Avg Return
11.8%
Net Assets
$1.08 B
Holdings in Top 10
55.1%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.16%
SALES FEES
Front Load 5.25%
Deferred Load N/A
TRADING FEES
Turnover 32.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Investment Style
Health
Name
Price
Aum/Mkt Cap
YIELD & DIV
Exp Ratio
Watchlist
ETHSX - Profile
Distributions
- YTD Total Return -17.6%
- 3 Yr Annualized Total Return 12.3%
- 5 Yr Annualized Total Return 10.6%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.30%
- Dividend Yield 0.3%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameEaton Vance Worldwide Health Sciences Fund
-
Fund Family NameEaton Vance
-
Inception DateJul 26, 1985
-
Shares Outstanding57392692
-
Share ClassA
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJason Kritzer
Fund Description
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.
ETHSX - Performance
Return Ranking - Trailing
| Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -17.6% | -41.2% | 25.3% | 47.87% |
| 1 Yr | 3.9% | -60.2% | 11.7% | 11.11% |
| 3 Yr | 14.3%* | -10.0% | 19.7% | 21.09% |
| 5 Yr | 11.8%* | -6.4% | 16.9% | 16.08% |
| 10 Yr | 13.7%* | 6.4% | 18.5% | 51.59% |
* Annualized
Return Ranking - Calendar
| Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | 12.3% | -79.9% | 24.2% | 15.79% |
| 2020 | 5.2% | -13.6% | 178.2% | 83.75% |
| 2019 | 19.3% | 3.8% | 63.8% | 65.03% |
| 2018 | 0.8% | -49.7% | 21.5% | 15.33% |
| 2017 | 13.1% | -59.8% | 54.4% | 67.41% |
Total Return Ranking - Trailing
| Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -17.6% | -46.5% | 25.3% | 42.55% |
| 1 Yr | -1.5% | -60.2% | 28.3% | 29.63% |
| 3 Yr | 12.3%* | -13.2% | 20.0% | 43.48% |
| 5 Yr | 10.6%* | -6.4% | 16.9% | 36.94% |
| 10 Yr | 13.1%* | 6.4% | 18.5% | 61.24% |
* Annualized
Total Return Ranking - Calendar
| Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | 12.3% | -79.9% | 24.2% | 15.79% |
| 2020 | 5.2% | -13.6% | 178.2% | 83.75% |
| 2019 | 19.3% | 3.8% | 63.8% | 65.03% |
| 2018 | 0.8% | -49.7% | 22.2% | 21.90% |
| 2017 | 16.2% | -59.8% | 54.4% | 68.15% |
NAV & Total Return History
ETHSX - Holdings
Concentration Analysis
| ETHSX | Category Low | Category High | ETHSX % Rank | |
|---|---|---|---|---|
| Net Assets | 1.08 B | 732 K | 46.2 B | 40.43% |
| Number of Holdings | 51 | 21 | 473 | 71.84% |
| Net Assets in Top 10 | 603 M | 2.18 K | 21.6 B | 33.98% |
| Weighting of Top 10 | 55.08% | 12.3% | 80.8% | 14.08% |
Top 10 Holdings
- Johnson & Johnson 8.74%
- UnitedHealth Group Inc 8.49%
- AbbVie Inc 6.20%
- Roche Holding AG 5.41%
- Eli Lilly and Co 5.17%
- AstraZeneca PLC 4.90%
- AstraZeneca PLC 4.90%
- AstraZeneca PLC 4.90%
- AstraZeneca PLC 4.90%
- AstraZeneca PLC 4.90%
Asset Allocation
| Weighting | Return Low | Return High | ETHSX % Rank | |
|---|---|---|---|---|
| Stocks | 99.55% | 85.37% | 106.13% | 41.75% |
| Cash | 0.32% | -0.10% | 9.01% | 57.28% |
| Preferred Stocks | 0.13% | 0.00% | 7.86% | 5.83% |
| Other | 0.00% | -22.99% | 3.38% | 48.06% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 42.72% |
| Bonds | 0.00% | 0.00% | 12.39% | 41.26% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | ETHSX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 59.26% | 100.00% | 22.82% |
| Utilities | 0.00% | 0.00% | 0.00% | 39.32% |
| Technology | 0.00% | 0.00% | 22.69% | 44.66% |
| Real Estate | 0.00% | 0.00% | 7.13% | 44.17% |
| Industrials | 0.00% | 0.00% | 7.02% | 43.69% |
| Financial Services | 0.00% | 0.00% | 1.85% | 53.40% |
| Energy | 0.00% | 0.00% | 0.00% | 39.32% |
| Communication Services | 0.00% | 0.00% | 9.11% | 42.72% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 47.09% |
| Consumer Cyclical | 0.00% | 0.00% | 14.20% | 42.72% |
| Basic Materials | 0.00% | 0.00% | 14.83% | 58.25% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | ETHSX % Rank | |
|---|---|---|---|---|
| US | 71.69% | 53.67% | 104.41% | 89.81% |
| Non US | 27.86% | 0.00% | 45.40% | 8.25% |
ETHSX - Expenses
Operational Fees
| ETHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.16% | 0.08% | 3.13% | 29.19% |
| Management Fee | 0.78% | 0.00% | 1.25% | 70.21% |
| 12b-1 Fee | 0.25% | 0.00% | 1.00% | 40.91% |
| Administrative Fee | 0.15% | 0.03% | 0.25% | 57.89% |
Sales Fees
| ETHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | 5.25% | 0.00% | 5.75% | 37.50% |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| ETHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| ETHSX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 32.00% | 0.00% | 238.00% | 30.67% |
ETHSX - Distributions
Dividend Yield Analysis
| ETHSX | Category Low | Category High | ETHSX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.29% | 0.00% | 9.45% | 48.82% |
Dividend Distribution Analysis
| ETHSX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Monthly | Semi-Annually |
Net Income Ratio Analysis
| ETHSX | Category Low | Category High | ETHSX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | 0.30% | -2.54% | 1.92% | 21.97% |
Capital Gain Distribution Analysis
| ETHSX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Semi-Annually |
Dividend Payout History
| Date | Amount | Type |
|---|---|---|
| Dec 05, 2018 | $0.035 | OrdinaryDividend |
| Dec 18, 2013 | $0.069 | OrdinaryDividend |
| Dec 21, 2012 | $0.231 | OrdinaryDividend |
ETHSX - Fund Manager Analysis
Managers
Jason Kritzer
Start Date
Tenure
Tenure Rank
Jul 01, 2016
5.92
5.9%
Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.
Samantha Pandolfi
Start Date
Tenure
Tenure Rank
Jul 01, 2016
5.92
5.9%
Ms. Pandolfi is a Vice President of EVAIL. Prior to joining EVAIL, Ms. Pandolfi held similar positions at EVMI. Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure (2000-2015).
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.54 | 2.12 |